NVS vs SILO
NVS (NVS) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
NVS (NVS) common stock.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
NVS does not have a complete income-statement cache yet.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
NVS currently screens at market cap $0. SILO currently screens at market cap $4.4M.
Not investment advice. Open the NVS and SILO stock pages for the full models.
Not investment advice.